| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/03/2007 | US20070098789 Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
| 05/03/2007 | US20070098788 Non-benzodiazepine hypnotic compositions |
| 05/03/2007 | US20070098787 Composition for preventing and treating varicose veins of lower extremities |
| 05/03/2007 | US20070098786 Enteric valproic acid |
| 05/03/2007 | US20070098785 Medicant delivery system and device |
| 05/03/2007 | US20070098784 Delivery system for biological component |
| 05/03/2007 | US20070098783 Hydrophilic Vehicle-Based Dual Controlled Release Matrix System |
| 05/03/2007 | US20070098782 Solid form; stabilized to control degradation to the active metabolite ramiprilat instead of ramipril diketopiperazine; hypertension, heart failure, stroke, myocardial infarction, diabetes and cardiovascular disease |
| 05/03/2007 | US20070098781 Modified release compositions for DPP-IV inhibitors |
| 05/03/2007 | US20070098780 Method for preparing a pharmaceutical compound by way of magnetic carbon nanocapsules |
| 05/03/2007 | US20070098779 Films and capsules made from modified carboxymethylcellulose materials |
| 05/03/2007 | US20070098778 Co-formulations or kits of bioactive agents |
| 05/03/2007 | US20070098777 Pharmaceutical or Food Composition for Treatment or Prevention of Brain Edema |
| 05/03/2007 | US20070098776 HLA class I A2 tumor associated antigen peptides and vaccine compositions |
| 05/03/2007 | US20070098775 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 05/03/2007 | US20070098774 Flexible transdermal drug delivery device for uniform penetration of chemodenervating botulinum toxins |
| 05/03/2007 | US20070098773 Flexible transdermal drug delivery device for uniform penetration of chemodenervating botulinum toxins |
| 05/03/2007 | US20070098772 Transdermal norelgestromin delivery system |
| 05/03/2007 | US20070098771 High enhancer-loading polyacrylate formulation for transdermal applications |
| 05/03/2007 | US20070098770 Cosmetic path using method thereof, and cosmetic path package |
| 05/03/2007 | US20070098768 Two-sided personal-care appliance for health, hygiene, and/or environmental application(s); and method of making said two-sided personal-care appliance |
| 05/03/2007 | US20070098767 Substrate and personal-care appliance for health, hygiene, and/or environmental applications(s); and method of making said substrate and personal-care appliance |
| 05/03/2007 | US20070098766 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous asorption, and process for producing the same |
| 05/03/2007 | US20070098765 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 05/03/2007 | US20070098764 Colon cleansing compositions and methods |
| 05/03/2007 | US20070098761 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/03/2007 | US20070098760 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |
| 05/03/2007 | US20070098748 Stabilized Formulations of alpha Adrenergic Receptor Antagonists and the Uses Thereof |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098746 Multi-layered coating technology for taste masking |
| 05/03/2007 | US20070098740 Stabilisation of viral microparticles |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098733 In ovo delivery of an immunogen containing implant |
| 05/03/2007 | US20070098713 Nanoparticle delivery systems and methods of use thereof |
| 05/03/2007 | US20070098710 Anxiolytic composition comprising essential oil derived from plants as active ingredients, anxiolytic comprising thereof, and a producing method thereof |
| 05/03/2007 | US20070098706 Polypeptide includes an NADPH oxidase cytosolic cofactor polypeptide NOXA1 or p67phox having a C-terminal SH3 domain insertion mutation of at least three consecutive amino acids positioned so as to reduce activity of the purified polypeptide relative to the wild-type cofactor polypeptide |
| 05/03/2007 | US20070098684 Methods of reducing aggregation of IL-1ra |
| 05/03/2007 | US20070098679 Methods and Compositions for Applying Pharmacologic Agents to the Ear |
| 05/03/2007 | US20070098678 Enteric coated aliphatic amine polymer bile acid sequestrants |
| 05/03/2007 | US20070098677 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/03/2007 | US20070098662 Cosmetic composition promoting oxygen transport into the skin |
| 05/03/2007 | US20070098648 Treating mouth sores caused by dental braces with blobs of hydrophilic gums |
| 05/03/2007 | US20070098646 Aerosol propellants comprising unsaturated fluorocarbons |
| 05/03/2007 | US20070098645 Intranasal delivery of compounds that reduce intrancranial pressure |
| 05/03/2007 | US20070098644 Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| 05/03/2007 | US20070096354 Process of making flowable hemostatic compositions and devices containing such compositions |
| 05/03/2007 | DE112005000725T5 Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten Methods and compositions for treatment of ion imbalance |
| 05/03/2007 | DE102006009599A1 Treibgasabsorbtion bei Dosieraerosolen mit Verpackungen Treibgasabsorbtion in MDIs with packaging |
| 05/03/2007 | DE102005051222A1 Liquid, cold-processable oil-in-water emulsifier system for, e.g. cosmetic preparation, has polyethylene glycol-free emulsifier base of polyol partial ester(s) and acid partial ester(s) carrying neutralizable or neutralized acid functions |
| 05/03/2007 | CA2627941A1 A delivery system |
| 05/03/2007 | CA2627657A1 A method for preparing liposomes and uses thereof |
| 05/03/2007 | CA2627608A1 Micronised azodicarbonamide, the preparation and use thereof |
| 05/03/2007 | CA2627463A1 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | CA2627343A1 Metal coordinated compositions |
| 05/03/2007 | CA2627271A1 Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable thereby |
| 05/03/2007 | CA2627223A1 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 05/03/2007 | CA2626881A1 Biodegradable particle and production method thereof |
| 05/03/2007 | CA2626579A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/03/2007 | CA2626562A1 Encapsulation and controlled release of biologically active ingredients with enzymatically degradable microparticulate hyper-branched polymers |
| 05/03/2007 | CA2626394A1 Yeast cell wall particle for delivering osteoprotegerin-encoding polynucleotide |
| 05/03/2007 | CA2626298A1 Propellant for dosing aerosols comprising packagings |
| 05/03/2007 | CA2626208A1 Topical pharmaceutical foam composition |
| 05/03/2007 | CA2625908A1 Starch coating agents |
| 05/03/2007 | CA2625856A1 Drug delivery systems |
| 05/03/2007 | CA2625676A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 05/03/2007 | CA2616416A1 Trazodone composition for once a day adminisitiation |
| 05/03/2007 | CA2616204A1 Sustained drug release composition |
| 05/03/2007 | CA2610723A1 Gold surfaces coated with a thermostable, chemically resistant polypeptide layer and applications thereof |
| 05/02/2007 | EP1779864A1 Pth-containing preparation for transmucosal administration |
| 05/02/2007 | EP1779855A1 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 05/02/2007 | EP1779854A1 Glycyrrhizin-containing suppository compositions for rectal infusion |
| 05/02/2007 | EP1779847A2 Osmotic delivery system with semipermeable plug |
| 05/02/2007 | EP1779846A2 A Delivery System for an Oral Care Substance using a Strip of Material having Low Flexural Stiffness |
| 05/02/2007 | EP1779076A1 A colour compensating system |
| 05/02/2007 | EP1778783A1 Polymer matrix containing water, consisting of hydrophobic polymers |
| 05/02/2007 | EP1778723A2 Il-1 antagonist formulations |
| 05/02/2007 | EP1778614A2 Invertible amphiphilic polymers |
| 05/02/2007 | EP1778361A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
| 05/02/2007 | EP1778340A1 Novel electrodes and uses thereof |
| 05/02/2007 | EP1778335A2 Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| 05/02/2007 | EP1778294A2 Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| 05/02/2007 | EP1778290A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
| 05/02/2007 | EP1778278A2 Gonadotropin releasing hormone antagonists |
| 05/02/2007 | EP1778263A2 Effervescent composition including a grape-derived component |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1778226A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
| 05/02/2007 | EP1778208A1 Extended-release capsules comprising venlafaxine hydrochloride |
| 05/02/2007 | EP1778203A2 Apparatus and method for transdermal delivery of natriuretic peptides |
| 05/02/2007 | EP1778202A1 Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease |
| 05/02/2007 | EP1778201A2 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 05/02/2007 | EP1778200A1 Nanocoating for improving biocompatibility of medical implants |
| 05/02/2007 | EP1778199A1 Compressed composite delivery system for release-rate modulation of bioactives |
| 05/02/2007 | EP1778198A1 Implantable device having reservoir with controlled release of medication and method of manufacturing the same |
| 05/02/2007 | EP1778197A2 Compositions and methods for nutrition supplementation |
| 05/02/2007 | EP1778196A2 Pharmaceutical dosage forms including rasagiline |
| 05/02/2007 | EP1778195A2 Anti-histaminic composition |
| 05/02/2007 | EP1778194A1 Process for preparing microcrystals |
| 05/02/2007 | EP1778193A2 Sustained release pharmaceutical particulate composition comprising venlafaxine |
| 05/02/2007 | EP1778192A2 Microparticulate systems for the oral administration of biologically active substances |